Literature DB >> 11982307

Babesiosis.

Peter J Krause1.   

Abstract

Babesiosis is an emerging infection caused by protozoal parasites and transmitted by the same tick that transmits Lyme disease. Babesiosis is found throughout the world, but most cases have been described from the northeastern and northern midwestern United States. Patients experience a flulike illness that usually lasts for 1 or 2 weeks but may require hospital admission. Those at greatest risk of fatal disease include individuals older than age 50 years; asplenic individuals; and immunocompromised individuals as a result of immunosuppressive drugs, malignancy, or HIV infection. Specific diagnosis is made through examination of a Giemsa-stained thin blood smear, DNA amplification using polymerase chain reaction, or detection of specific antibody. Treatment consists of clindamycin and quinine or atovaquone and azithromycin and, in severe cases, exchange transfusion.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11982307     DOI: 10.1016/s0025-7125(03)00092-0

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN: 0025-7125            Impact factor:   5.456


  22 in total

Review 1.  Human granulocytic anaplasmosis.

Authors:  Johan S Bakken; J Stephen Dumler
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 2.  Coinfections acquired from ixodes ticks.

Authors:  Stephen J Swanson; David Neitzel; Kurt D Reed; Edward A Belongia
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

3.  Experimental transfusion-induced Babesia microti infection: dynamics of parasitemia and immune responses in a rhesus macaque model.

Authors:  Sanjeev Gumber; Fernanda S Nascimento; Kenneth A Rogers; Henry S Bishop; Hilda N Rivera; Maniphet V Xayavong; Sushil G Devare; Gerald Schochetman; Praveen K Amancha; Yvonne Qvarnstrom; Patricia P Wilkins; François Villinger
Journal:  Transfusion       Date:  2016-02-19       Impact factor: 3.157

4.  Some aspects on tick species in Mongolia and their potential role in the transmission of equine piroplasms, Anaplasma phagocytophilum and Borrelia burgdorferi L.

Authors:  Myadagsuren Narankhajid; Chultemsuren Yeruult; Agvaandaram Gurbadam; Jigjav Battsetseg; Stephan W Aberle; Badamdorj Bayartogtokh; Anja Joachim; Georg Gerhard Duscher
Journal:  Parasitol Res       Date:  2018-09-03       Impact factor: 2.289

Review 5.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

6.  Babesia microti primarily invades mature erythrocytes in mice.

Authors:  Ingo Borggraefe; Jie Yuan; Sam R Telford; Sanjay Menon; Rouette Hunter; Sohela Shah; Andrew Spielman; Jeffrey A Gelfand; Henry H Wortis; Edouard Vannier
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

7.  Detection of Babesia divergens using molecular methods in anemic patients in Shandong Province, China.

Authors:  Chunhua Qi; Dong Zhou; Jianzhu Liu; Ziqiang Cheng; Li Zhang; Lin Wang; Zhenyong Wang; Dubao Yang; Shujing Wang; Tongjie Chai
Journal:  Parasitol Res       Date:  2011-04-19       Impact factor: 2.289

8.  Associations between coinfection prevalence of Borrelia lusitaniae, Anaplasma sp., and Rickettsia sp. in hard ticks feeding on reptile hosts.

Authors:  Radovan Václav; Martina Ficová; Pavol Prokop; Tatiana Betáková
Journal:  Microb Ecol       Date:  2010-08-14       Impact factor: 4.552

9.  Effect of sex steroids on Babesia microti infection in mice.

Authors:  Mizuki Sasaki; Yoshito Fujii; Maya Iwamoto; Hiromi Ikadai
Journal:  Am J Trop Med Hyg       Date:  2012-12-18       Impact factor: 2.345

10.  Cellular immunity, but not gamma interferon, is essential for resolution of Babesia microti infection in BALB/c mice.

Authors:  Michael L Clawson; Natalia Paciorkowski; T V Rajan; Carson La Vake; Conny Pope; Morgan La Vake; Stephen K Wikel; Peter J Krause; Justin D Radolf
Journal:  Infect Immun       Date:  2002-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.